» Articles » PMID: 32573845

Heterogeneity of Cancer-associated Fibroblasts: Opportunities for Precision Medicine

Overview
Journal Cancer Sci
Specialty Oncology
Date 2020 Jun 24
PMID 32573845
Citations 102
Authors
Affiliations
Soon will be listed here.
Abstract

Despite marked development in cancer therapies during recent decades, the prognosis for advanced cancer remains poor. The conventional tumor-cell-centric view of cancer can only explain part of cancer progression, and thus a thorough understanding of the tumor microenvironment (TME) is crucial. Among cells within the TME, cancer-associated fibroblasts (CAFs) are attracting attention as a target for cancer therapy. However, CAFs present a heterogeneous population of cells and more detailed classification of CAFs and investigation of functions of each subset is needed to develop novel CAF-targeted therapies. In this context, application of newly developed approaches to single-cell analysis has already made an impact on our understanding of the heterogeneity of CAFs. Here, we review the recent literature on CAF heterogeneity and function, and discuss the possibility of novel therapies targeting CAF subsets.

Citing Articles

Prognostic and Therapeutic Significance of Cancer-Associated Fibroblasts Genes in Osteosarcoma Based on Bulk and Single-Cell RNA Sequencing Data.

Que Y, Ding T, Wang H, Xu S, He P, Shen Q J Cell Mol Med. 2025; 29(5):e70424.

PMID: 40045162 PMC: 11882394. DOI: 10.1111/jcmm.70424.


LMO7 drives profibrotic fibroblast polarization and pulmonary fibrosis in mice through TGF-β signalling.

Sun L, Zhang H, Jiang H, Li W, Li M, Yang X Acta Pharmacol Sin. 2025; .

PMID: 40000880 DOI: 10.1038/s41401-025-01488-9.


C3 cancer-associated fibroblasts promote tumor growth and therapeutic resistance in gastric cancer via activation of the NF-κB signaling pathway.

Zhao Z, Xiong S, Gao J, Zhang Y, Guo E, Huang Y J Transl Med. 2024; 22(1):1130.

PMID: 39707456 PMC: 11662460. DOI: 10.1186/s12967-024-05939-5.


The characteristics and functional significance of disulfidptosis-related genes in head and neck squamous cell carcinoma.

Zhu H, Zhao C, Zhu H, Xu X, Hu C, Zhang Z Discov Oncol. 2024; 15(1):739.

PMID: 39625660 PMC: 11615178. DOI: 10.1007/s12672-024-01629-2.


Bone mineral density affects tumor growth by shaping microenvironmental heterogeneity.

Whitman M, Mantri M, Spanos E, Estroff L, De Vlaminck I, Fischbach C Biomaterials. 2024; 315:122916.

PMID: 39490060 PMC: 11658005. DOI: 10.1016/j.biomaterials.2024.122916.


References
1.
Herrera M, Islam A, Herrera A, Martin P, Garcia V, Silva J . Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature. Clin Cancer Res. 2013; 19(21):5914-26. DOI: 10.1158/1078-0432.CCR-13-0694. View

2.
Zeisberg E, Potenta S, Xie L, Zeisberg M, Kalluri R . Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 2007; 67(21):10123-8. DOI: 10.1158/0008-5472.CAN-07-3127. View

3.
Neuzillet C, Tijeras-Raballand A, Ragulan C, Cros J, Patil Y, Martinet M . Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma. J Pathol. 2018; 248(1):51-65. PMC: 6492001. DOI: 10.1002/path.5224. View

4.
Ohlund D, Handly-Santana A, Biffi G, Elyada E, Almeida A, Ponz-Sarvise M . Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017; 214(3):579-596. PMC: 5339682. DOI: 10.1084/jem.20162024. View

5.
Hinz B, Phan S, Thannickal V, Galli A, Bochaton-Piallat M, Gabbiani G . The myofibroblast: one function, multiple origins. Am J Pathol. 2007; 170(6):1807-16. PMC: 1899462. DOI: 10.2353/ajpath.2007.070112. View